TYME - タイム・テクノロジ―ズ (Tyme Technologies Inc.)

TYMEのニュース

   Tyme Technologies (NASDAQ:TYME) Upgraded to “Buy” at Zacks Investment Research  2020/11/20 13:50:46 Transcript Daily
Zacks Investment Research upgraded shares of Tyme Technologies (NASDAQ:TYME) from a hold rating to a buy rating in a research note published on Thursday morning, Zacks.com reports. They currently have $1.00 price objective on the stock. According to Zacks, “Tyme Technologies, Inc. is a pharmaceutical company. The company is focused on creating medicines which specialize […]
   Tyme Technologies Inc (NASDAQ:TYME) CEO Steve Hoffman Sells 37,842 Shares of Stock  2020/10/24 10:52:43 Zolmax News
Tyme Technologies Inc (NASDAQ:TYME) CEO Steve Hoffman sold 37,842 shares of Tyme Technologies stock in a transaction that occurred on Thursday, October 22nd. The stock was sold at an average price of $0.98, for a total value of $37,085.16. Following the completion of the sale, the chief executive officer now owns 25,929,946 shares in the […]
   Steve Hoffman Sells 37,842 Shares of Tyme Technologies Inc (NASDAQ:TYME) Stock  2020/10/23 22:10:41 US Banking News
Tyme Technologies Inc (NASDAQ:TYME) CEO Steve Hoffman sold 37,842 shares of the firm’s stock in a transaction that occurred on Thursday, October 22nd. The shares were sold at an average price of $0.98, for a total transaction of $37,085.16. Steve Hoffman also recently made the following trade(s): On Wednesday, October 7th, Steve Hoffman sold 62,500 […]
   Michael Demurjian Sells 20,000 Shares of Tyme Technologies Inc (NASDAQ:TYME) Stock  2020/10/21 09:04:41 Dakota Financial News
Tyme Technologies Inc (NASDAQ:TYME) major shareholder Michael Demurjian sold 20,000 shares of the firm’s stock in a transaction that occurred on Friday, October 16th. The shares were sold at an average price of $1.02, for a total transaction of $20,400.00. Following the completion of the sale, the insider now owns 25,198,546 shares in the company, […]
   Tyme Technologies Inc (NASDAQ:TYME) Major Shareholder Sells $20,400.00 in Stock  2020/10/21 09:04:41 Zolmax News
Tyme Technologies Inc (NASDAQ:TYME) major shareholder Michael Demurjian sold 20,000 shares of the company’s stock in a transaction on Friday, October 16th. The shares were sold at an average price of $1.02, for a total transaction of $20,400.00. Following the completion of the sale, the insider now directly owns 25,198,546 shares of the company’s stock, […]
   Tyme Technologies Inc (NASDAQ:TYME) CEO Steve Hoffman Sells 37,842 Shares of Stock  2020/10/24 10:52:43 Zolmax News
Tyme Technologies Inc (NASDAQ:TYME) CEO Steve Hoffman sold 37,842 shares of Tyme Technologies stock in a transaction that occurred on Thursday, October 22nd. The stock was sold at an average price of $0.98, for a total value of $37,085.16. Following the completion of the sale, the chief executive officer now owns 25,929,946 shares in the […]
   Steve Hoffman Sells 37,842 Shares of Tyme Technologies Inc (NASDAQ:TYME) Stock  2020/10/23 22:10:41 US Banking News
Tyme Technologies Inc (NASDAQ:TYME) CEO Steve Hoffman sold 37,842 shares of the firm’s stock in a transaction that occurred on Thursday, October 22nd. The shares were sold at an average price of $0.98, for a total transaction of $37,085.16. Steve Hoffman also recently made the following trade(s): On Wednesday, October 7th, Steve Hoffman sold 62,500 […]
   Michael Demurjian Sells 20,000 Shares of Tyme Technologies Inc (NASDAQ:TYME) Stock  2020/10/21 09:04:41 Dakota Financial News
Tyme Technologies Inc (NASDAQ:TYME) major shareholder Michael Demurjian sold 20,000 shares of the firm’s stock in a transaction that occurred on Friday, October 16th. The shares were sold at an average price of $1.02, for a total transaction of $20,400.00. Following the completion of the sale, the insider now owns 25,198,546 shares in the company, […]
   Tyme Technologies Inc (NASDAQ:TYME) Major Shareholder Sells $20,400.00 in Stock  2020/10/21 09:04:41 Zolmax News
Tyme Technologies Inc (NASDAQ:TYME) major shareholder Michael Demurjian sold 20,000 shares of the company’s stock in a transaction on Friday, October 16th. The shares were sold at an average price of $1.02, for a total transaction of $20,400.00. Following the completion of the sale, the insider now directly owns 25,198,546 shares of the company’s stock, […]
   Insider Selling: Tyme Technologies Inc (NASDAQ:TYME) Major Shareholder Sells 20,000 Shares of Stock  2020/10/20 16:50:41 US Banking News
Tyme Technologies Inc (NASDAQ:TYME) major shareholder Michael Demurjian sold 20,000 shares of the firm’s stock in a transaction on Monday, October 19th. The shares were sold at an average price of $1.03, for a total value of $20,600.00. Following the completion of the transaction, the insider now owns 25,178,546 shares in the company, valued at […]
   Tyme Technologies to Present at Canaccord 40th Annual Growth Conference on August 13, 2020  2020/07/21 12:00:00 Business Wire
NEW YORK--(BUSINESS WIRE)---- $TYME--Tyme Technologies, Inc. (NASDAQ: TYME), an emerging biotechnology company developing cancer metabolism-based therapies (CMBTs™), announced that its leadership will participate at the Canaccord 40th Annual Growth Conference on Thursday, August 13, 2020. The Company will present its corporate overview for 2020 with a special focus on multiple growth opportunities driven by advances in the science of cancer metabolism, pivotal and late-stage trials in pancreatic cancer,
   TYME Provides Business Update and Announces Preliminary First Quarter Fiscal 2021 Financial and Operating Results  2020/07/13 21:00:00 Business Wire
NEW YORK--(BUSINESS WIRE)---- $TYME--Tyme Technologies, Inc. (NASDAQ: TYME), an emerging biotechnology company developing cancer metabolism-based therapies (CMBTs™), announced preliminary financial and operating results for its first fiscal quarter ended June 30, 2020. During first quarter fiscal 2021, the Company presented a growing body of preclinical and clinical data at major international medical meetings; continued enrolling patients in multiple studies including, second and third-line pancreatic c
   Tyme Technologies Announces Virtual 2020 Annual Meeting of Stockholders  2020/07/10 12:00:00 Business Wire
NEW YORK--(BUSINESS WIRE)---- $TYME--Tyme Technologies, Inc. (NASDAQ: TYME), an emerging biotechnology company developing cancer metabolism-based therapies (CMBTs™), announced that TYME will hold its 2020 Annual Meeting of Stockholders in a virtual-only format, as a result of public health concerns relating to the coronavirus (COVID-19) and to protect the health and well-being of its shareholders, directors, employees and the public, on Thursday, August 20, 2020, at 11:00 AM Eastern Time. Stockholders wi
   Edited Transcript of TYME.OQ earnings conference call or presentation 20-May-20 9:00pm GMT  2020/06/29 03:11:29 Yahoo Finance
Q4 2020 Tyme Technologies Inc Earnings Call
   TYME-18 Demonstrates Anti-Cancer Effect in New Preclinical Data Presented at AACR 2020  2020/06/23 12:00:00 Business Wire
NEW YORK--(BUSINESS WIRE)---- $TYME--Tyme Technologies, Inc. (NASDAQ: TYME), an emerging biotechnology company developing cancer metabolism-based therapies (CMBTs™), announced new preclinical findings that describe the unique anti-cancer effects of its cancer metabolism-based pipeline candidate, TYME-18, that are being presented at the American Association for Cancer Research 2020 Virtual Meeting from June 22 to June 24, 2020. TYME’s CMBTs are proprietary investigational compounds that leverage cancer’s

calendar